Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.5200 (-8.4%) ($13.2300 - $15.0500) on Thu. Feb. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 52 | Latest Price | $13.5200(-8.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.8% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 0 () | Intraday Trend | -9% | | | |
|
Resistance Level | $14.01 | 5 Day Moving Average | $14.15(-4.45%) | 10 Day Moving Average | $14.14(-4.38%) | 20 Day Moving Average | $14.01(-3.5%) | To recent high | -24% | To recent low | 2.6% | Market Cap | $1.005b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |